These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. During MJ; Kaplitt MG; Stern MB; Eidelberg D Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246 [TBL] [Abstract][Full Text] [Related]
3. Xenotransplantation of cells and tissues: application to a range of diseases, from diabetes to Alzheimer's. Lanza RP; Cooper DK Mol Med Today; 1998 Jan; 4(1):39-45. PubMed ID: 9494969 [TBL] [Abstract][Full Text] [Related]
4. Advances in cell therapy for renal failure. Humes HD; Szczypka MS Transpl Immunol; 2004 Apr; 12(3-4):219-27. PubMed ID: 15157916 [TBL] [Abstract][Full Text] [Related]
5. Current regulatory issues in cell and tissue therapy. Burger SR Cytotherapy; 2003; 5(4):289-98. PubMed ID: 12944234 [TBL] [Abstract][Full Text] [Related]
6. A human stem cell project? Nature; 2002 Jul; 418(6893):1. PubMed ID: 12097865 [No Abstract] [Full Text] [Related]
7. Future directions: use of interventional MRI for cell-based therapy of Parkinson disease. Roskom J; Swistowski A; Zeng X; Lim DA Neurosurg Clin N Am; 2009 Apr; 20(2):211-8. PubMed ID: 19555884 [TBL] [Abstract][Full Text] [Related]
8. [Cell therapy in Parkinson's disease]. Shingo T Rinsho Shinkeigaku; 2004 Nov; 44(11):951-3. PubMed ID: 15651341 [TBL] [Abstract][Full Text] [Related]
9. The search for a curative cell therapy in Parkinson's disease. Laguna Goya R; Tyers P; Barker RA J Neurol Sci; 2008 Feb; 265(1-2):32-42. PubMed ID: 17936303 [TBL] [Abstract][Full Text] [Related]
11. Assessing fetal nerve cell grafts in Parkinson's disease. Braak H; Del Tredici K Nat Med; 2008 May; 14(5):483-5. PubMed ID: 18463652 [No Abstract] [Full Text] [Related]
12. The use of neural stem cells for gene therapy in the central nervous system. Björklund A J Gene Med; 1999; 1(3):223-6. PubMed ID: 10738570 [No Abstract] [Full Text] [Related]
13. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases. Resnick IB; Shapira MY; Slavin S Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565 [TBL] [Abstract][Full Text] [Related]
14. [Cell therapy and other neuroregenerative strategies in Parkinson's disease (II)]. Mínguez-Castellanos A; Escamilla-Sevilla F Rev Neurol; 2005 Dec 1-15; 41(11):684-93. PubMed ID: 16317638 [TBL] [Abstract][Full Text] [Related]
15. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease. Levy YS; Bahat-Stroomza M; Barzilay R; Burshtein A; Bulvik S; Barhum Y; Panet H; Melamed E; Offen D Cytotherapy; 2008; 10(4):340-52. PubMed ID: 18574767 [TBL] [Abstract][Full Text] [Related]
16. The cellular repair of the brain in Parkinson's disease--past, present and future. Sayles M; Jain M; Barker RA Transpl Immunol; 2004 Apr; 12(3-4):321-42. PubMed ID: 15157925 [TBL] [Abstract][Full Text] [Related]
17. [Cell therapy and arrhythmias: state of the art]. Mattioli AV G Ital Cardiol (Rome); 2008 Apr; 9(4):251-61. PubMed ID: 18543794 [TBL] [Abstract][Full Text] [Related]
18. Prospects in xenotransplantation: a personal view. Groth CG Transplant Proc; 2007 Apr; 39(3):685-7. PubMed ID: 17445573 [TBL] [Abstract][Full Text] [Related]